STAA STAAR SURGICAL CO

Overview and Growth

In fiscal 2025, STAAR SURGICAL CO recorded $239.44M of revenue, net loss of $80.45M, and an operating cash outflow of $34.23M. At $239.44M, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Compared with $313.90M in fiscal 2024, revenue decreased 23.7%, a top-line contraction that reduced operating scale. Diluted earnings per share were -$1.62, translating the period’s attributable earnings into the amount reported for each diluted share. The diluted weighted-average share count was 49.57M, linking total earnings with the per-share result received by shareholders. At period end, total assets were $451.68M, framing the scale of the company’s operating and financing commitments. The revenue-to-assets relationship was 0.53x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

After reported cost of revenue, the company retained $182.42M as gross profit before recognizing operating expenses and other items. Gross margin was 76.2%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was an operating loss of $91.71M, reflecting costs that exceeded gross profit. An operating margin of -38.3% reflected costs exceeding revenue-level gross profit by 38.3% of sales. The company ended the period with a net loss of $80.45M, extending the operating result through all remaining items. The net loss equaled 33.6% of revenue, showing the bottom-line deficit relative to the company’s sales base. Negative EBITDA totaled $83.39M, confirming that the earnings deficit remained before depreciation and amortization. The company reported a pretax loss of $82.26M, before the effect of income taxes. Measured against revenue, the pretax deficit represented 34.4%. An income-tax benefit of $1.81M improved the final result relative to pretax income or loss. Relative to period-end equity, the net loss represented 23.4%. The loss-to-assets relationship was 17.8%, placing the bottom-line deficit against the company’s resource base. The bottom-line deficit increased from $20.21M in fiscal 2024 to $80.45M.

Liquidity and Capital Structure

Total assets were $451.68M, supported by $107.49M of liabilities and $344.18M of shareholder equity. At period end, current assets of $311.55M compared with current liabilities of $68.50M, defining the company’s short-term resource position. At 4.55x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. The company held $153.15M in cash and equivalents, a narrower liquidity measure than total current assets. Cash and equivalents represented 223.6% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. Equity equaled 76.2% of assets, showing the shareholder-capital layer within the company’s balance sheet. Liabilities represented 23.8% of total assets, quantifying the liability-funded share of the company’s resource base. Measured against total assets, cash and equivalents represented 33.9%, a balance-sheet composition measure rather than a liquidity forecast. The asset base changed 11.4% from $509.52M in fiscal 2024, leaving current total assets lower year over year. Against $397.33M of equity in fiscal 2024, the current book-equity balance moved 13.4% and ended lower. Cash and equivalents were 6.2% higher than fiscal 2024 cash of $144.16M, showing the year-over-year change in liquid resources.

Cash Flow and Earnings Quality

The company reported an operating cash outflow of $34.23M, rather than cash generation from operations. Capital spending of $5.82M added to the period’s operating cash use, reinforcing the overall cash deficit after investment for the year. Operating cash flow and capital spending combined to leave a $40.05M cash deficit after capital spending. Relative to revenue, the post-investment cash deficit represented 16.7%. The cash deficit after capital spending represented 8.9% of the period-end asset base.

Based on the annual report for the fiscal year ending Jan 2, 2026. Analysis generated Oct 21, 2026.